Associate Senior Scientist

Be part of something altogether life-changing!

Working at Cytiva in the Life Sciences industry means being at the forefront of providing new solutions to transform human health. Our incredible customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, new medicines, and cell and gene therapies.

At Cytiva you will be able to continuously improve yourself and us – working on challenges that truly matter with people that care for each other, our customers, and their patients. With associates across 40 countries, Cytiva is a place where every day is a learning opportunity – so you can grow your career and expand your skills in the long term.

Forming part of the Biotechnology segment at Danaher, we bring together dedicated technical expertise and talent to develop the next generation of life-changing therapeutics.

The Associate Senior Scientist is responsible for leading research into nucleic acid design and production that will drive innovation at Cytiva.

This position is part of the Nucleic Acids & Nanomedicine group located in Vancouver, BC and will be on-site. At Cytiva, our vision is, to advance future therapeutics from discovery to delivery.

What you’ll do:

• Plan and execute projects, as part of a diverse bioengineering team, for process and technology development programs within the Nucleic Acid Therapeutics field.
• Provide day-to-day direction to project technical teams.
• Demonstrate continuous integrity, credibility and positivity, and motivate others to do the same.
• Continuously grow and adapt in a fast-moving field to keep yourself and the organization at the forefront of the Nucleic Acid Therapeutics field.
  
  

Who you are:

• Bachelors or Masters with 6+ years’ experience, or PhD with 3+ years’ experience in biochemistry, microbiology, biotechnology, or a related field. Exceptional knowledge of mRNA, nucleic acids and associated biology/biochemistry principles strongly preferred.
• Industry experience required in one or more of the following areas: bioprocess development, in vitro transcription, oligonucleotide delivery, lipid nanoparticle technologies, and/or downstream purification of nucleic acids.
• Team leadership experience and project management experience is a plus.
• Independent, detailed-oriented, self-starter with excellent analytical skills with the ability to multi-task and succeed in a team environment.
• Strong written and verbal English communications skills with solid knowledge of MS Office and comfort with learning new software applications especially those for DoE and statistical analysis.
  
  

The salary range for this role is 90,000 - 115,000 CAD. This is the range that we in good faith believe is the range of possible compensation for this role at the time of this posting. We may ultimately pay more or less than the posted range. This range may be modified in the future.

This job is also eligible for bonus/incentive pay.

We offer comprehensive package of benefits including paid time off, medical/dental/vision insurance and retirement benefits for eligible employees.

Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, benefits, or any other form of compensation and benefits that are allocable to a particular employee remains in the Company's sole discretion unless and until paid and may be modified at the Company’s sole discretion, consistent with the law.

Join our winning team today. Together, we’ll accelerate the real-life impact of tomorrow’s science and technology. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life.

For more information, visit www.danaher.com.

At Danaher, we value diversity and the existence of similarities and differences, both visible and not, found in our workforce, workplace and throughout the markets we serve. Our associates, customers and shareholders contribute unique and different perspectives as a result of these diverse attributes.